| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -3.3e-05 | 1 |